John Schmid P.'s most recent trade in AnaptysBio Inc was a trade of 6,030 Common Stock done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | John P. Schmid | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 6,030 | 37,652 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | John P. Schmid | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 6,030 | 0 | - | - | Restricted Stock Unit | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 6,030 | 37,652 | - | 0 | Common Stock | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 6,030 | 0 | - | - | Restricted Stock Unit | |
| Design Therapeutics Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 42,000 | 42,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 15,000 | 15,000 | - | - | Restricted Stock Unit | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2026 | 2,500 | 2,500 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John P. Schmid | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Apr 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | John P. Schmid | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | John P. Schmid | Director | Sale of securities on an exchange or to another person at price $ 55.71 per share. | 30 Mar 2026 | 12,596 | 39,671 (0%) | 0% | 55.7 | 701,707 | Common Stock |
| AnaptysBio Inc | John P. Schmid | Director | Sale of securities on an exchange or to another person at price $ 56.70 per share. | 30 Mar 2026 | 7,527 | 32,144 (0%) | 0% | 56.7 | 426,782 | Common Stock |
| AnaptysBio Inc | John P. Schmid | Director | Sale of securities on an exchange or to another person at price $ 57.40 per share. | 30 Mar 2026 | 522 | 31,622 (0%) | 0% | 57.4 | 29,962 | Common Stock |
| AnaptysBio Inc | John Schmid P. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | John Schmid P. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit |